MUC1-C functions as a common effector of acquired NSCLC cell resistance to TKIs associated with pleotropic mechanisms, including the epithelial mesenchymal transition (EMT), MET amplification and secondary EGFR(T790M/C797S) mutation [22]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.